Adamas Pharmaceuticals Inc Business Finance Contracts & Agreements

23 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to Asset Purchase Agreement between Adamas Pharmaceuticals, Inc., Adamas Pharma, LLC, and Osmotica Entities
Purchase Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2021
Adamas Pharmaceuticals, Inc. Performance Restricted Stock Unit Grant Notice and Award Agreement (2014 Equity Incentive Plan)
Equity Distribution Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2021
Adamas Pharmaceuticals, Inc. Underwriting Agreement for 12,500,000 Shares of Common Stock with SVB Leerink LLC and William Blair & Company, L.L.C.
Underwriting Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2021
Amendment No. 3 to Loan Agreement between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P.
Loan Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2021
Asset Purchase Agreement between Osmotica Pharmaceutical US LLC, Osmotica Holdings US LLC, and Adamas Pharmaceuticals, Inc. (December 1, 2020)
Purchase Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2021
Amendment No. 2 to Loan Agreement between HealthCare Royalty Partners III, L.P. and Adamas Pharma, LLC
Loan Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2020
Description of Adamas Pharmaceuticals, Inc. Common Stock and Related Rights
Stock Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2020
Secured Promissory Note (Subsequent Tranche Loan) between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P.
Note Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2018
Adamas Pharmaceuticals, Inc. Underwriting Agreement for 3,000,000 Shares of Common Stock with Merrill Lynch, Leerink Partners, and Evercore Group
Underwriting Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2018
Secured Promissory Note (Initial Tranche Loan) between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P.
Note Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2017
Loan Agreement between HealthCare Royalty Partners III, L.P. and Adamas Pharma, LLC dated May 11, 2017
Loan Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2017
Common Stock Sales Agreement between Adamas Pharmaceuticals, Inc. and Cowen and Company, LLC
Equity Distribution Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2017
Adamas Pharmaceuticals, Inc. Restricted Stock Unit Award Agreement (2014 Equity Incentive Plan)
Equity Distribution Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2016
Underwriting Agreement for Sale of 2,500,000 Shares of Common Stock by Adamas Pharmaceuticals, Inc. to Cowen and Company, LLC, Piper Jaffray & Co., and Other Underwriters
Underwriting Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2016
Adamas Pharmaceuticals Inc. 2014 Equity Incentive Plan Stock Option Grant Notice and Agreement
Equity Distribution Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2015
Adamas Pharmaceuticals, Inc. 2014 Equity Incentive Plan
Equity Distribution Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2014
Adamas Pharmaceuticals, Inc. 2014 Employee Stock Purchase Plan
Stock Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2014
Underwriting Agreement between Adamas Pharmaceuticals, Inc. and Credit Suisse Securities (USA) LLC and Piper Jaffray & Co. (2014)
Underwriting Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2014
Fourth Amended and Restated Investors' Rights Agreement by and among Adamas Pharmaceuticals, Inc. and Investors, June 30, 2011
Investor Rights Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2014
Adamas Pharmaceuticals, Inc. 2014 Employee Stock Purchase Plan
Stock Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2014
Adamas Pharmaceuticals, Inc. 2014 Equity Incentive Plan
Equity Distribution Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2014
Adamas Pharmaceuticals, Inc. 2007 Stock Plan (as Amended Through September 3, 2013)
Stock Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2014
Neuromolecular, Inc. 2002 Employee, Director and Consultant Stock Plan
Stock Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2014